According to the researchers, the global market for hemostasis analyzers can be studied on the basis of the type of test, type of product, end user, and the geographical spread of this market. Based on the type of test, the market can be classified into prothrombin time test and activated partial thromboplastin time. Based on the type of product, the market can be classified into semi-automated analyzers, fully-automated analyzers, and reagents and consumables. By end user, the market can be segmented into hospitals, private and academic research institutes, clinical testing laboratories, and commercial organizations. Hospitals, among these, has emerged as the leading end user of hemostasis analyzers across the world, states the research report.
A new research study on the global market for hemostasis analyzers by Transparency Market Research (TMR) provides an in-depth and unbiased assessment of this market considering its past performance and current status. The research report is titled “Hemostasis Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015–2023,” and it has analyzed the driving factors, key trends, limitations, opportunities, challenges, and growth prospects of this market to predict its future status.
Download PDF brochure for this Report:
As per the research study, the consistent technological advancements in laser, molecular diagnostics, and monoclonal antibodies is likely to act as the key driving force behind the tremendous growth of the global market for hemostasis analyzers over the next few years. The rise in understanding of the involvement of immune system for the regulation of systemic diseases is also projected to have a significant impact on this market in the near future.
In addition to this, technological advancements, resulting in the reduction of the production cost of instruments, and allowing the development of auto-calibration, advanced self-troubleshooting, and other features, will fuel the demand for hemostasis analyzers across the world in the years to come, notes the research study.
On the geographical front, the worldwide market for hemostasis analyzers can be segmented into North America, Asia Pacific, Europe, and the Rest of the World, including Latin America and the Middle East and Africa. Owing to the expanding installed instrument base, resulting in the increased sales of reagents and support services, North America has acquired the leading position in this market. The trend is expected to remain so over the next few years, report the market study.
Hemosonics LLC, Abbott Inc., Beckman Coulter Inc., Agilent Technologies, Drew Scientific Inc., Horiba Ltd., Grifols SA, Roche Diagnostics, Sysmex Corp., Siemens Healthcare, and Mindray Corp. are the leading vendors of hemostasis analyzers across the world, states the research report.
Browse Full Research Report on Hemostasis Analyzers Market:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.